Medication info
Jadiplosing M Tablet 12.5/1000 mg (Empagliflozin, Metformin Hydrochloride)

Jadiplosing M Tablet 12.5/1000 mg (Empagliflozin, Metformin Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin›12.5mg / 1 tabletMetformin Hydrochloride›1000mg / 1 tablet
Manufacturer / importer
Youngpoong Pharmaceutical Co., Ltd.
Appearance
Biconvex oval film-coated tablet with a dark brownish purple color
Packaging
30 tablets/bottle, 60 tablets/bottle, 10 tablets/box (10 tablets/PTP x 1), 60 tablets/box (10 tablets/PTP x 6)
Approval status
Active

MFDS item code 202302696 · Approved 2023.09.11 · Insurance code 661905790

Summary

Main use
Improvement of glycemic control in adults with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients who cannot achieve adequate glycemic control with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose of 10 mg) and their current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching from combination therapy with empagliflozin (total daily dose of 10 mg or 25 mg) and metformin to this medicine should take the same doses of empagliflozin and metformin as they were previously taking. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If a dose of this medicine is missed, take it as soon as you remember. However, do not take a double dose at one time; skip the missed dose in such cases. Special populations Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other symptoms that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual single-ingredient products empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to a CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use, 2. Patients Who Should Not Take This Medicine, item 2)). Older patients In patients aged 75 years or older, renal function and the risk of volume depletion should be taken into consideration.

Ingredients

Manufacturer
Youngpoong Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in adults with type 2 diabetes mellitus

  • Difficulty controlling blood sugar
  • type 2 diabetes
  • cardiovascular disease
View approved original text

This medication is used to assist in blood glucose control for adults with type 2 diabetes by combining empagliflozin and metformin. It is most effective when taken together with dietary and exercise therapies and is suitable for patients whose blood glucose is not adequately controlled. Caution is required, especially for patients with cardiovascular diseases, so it is important to follow professional guidance. This medication helps improve blood glucose control, thus aiding in diabetes management.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients who cannot achieve adequate glycemic control with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose of 10 mg) and their current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching from combination therapy with empagliflozin (total daily dose of 10 mg or 25 mg) and metformin to this medicine should take the same doses of empagliflozin and metformin as they were previously taking. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If a dose of this medicine is missed, take it as soon as you remember. However, do not take a double dose at one time; skip the missed dose in such cases. Special populations Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other symptoms that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual single-ingredient products empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to a CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use, 2. Patients Who Should Not Take This Medicine, item 2)). Older patients In patients aged 75 years or older, renal function and the risk of volume depletion should be taken into consideration.

Precautions

This medication can cause a rare but serious metabolic side effect called severe lactic acidosis; therefore, it should not be administered to patients with impaired kidney function or those with serious infections, dehydration, or cardiovascular disease. The risk of hypoglycemia may increase when this medication is used with other diabetes medications, so patients taking insulin or sulfonylureas should closely monitor blood glucose changes. Patients with moderate to severe kidney impairment, those with acute kidney injury, patients with acute or chronic metabolic acidosis, patients with acute heart failure, pregnant or breastfeeding women, and specific patient groups should not use this medication. Regular monitoring of kidney function and serum creatinine levels is important before starting or during treatment with this medication to monitor kidney status. Patients at risk of fluid loss or elderly patients and those who are dehydrated should be especially cautious as this medication can lower blood pressure or cause dehydration. This medication may increase the risk of urinary tract infections and genital infections, so if infection symptoms appear, immediate consultation with healthcare professionals is necessary. Women who are pregnant or may become pregnant and those who are breastfeeding should not take this medication. Patients preparing for surgery should stop taking this medication 48 hours prior and resume after kidney function has returned to normal following surgery. Alcohol consumption may increase the risk of lactic acidosis, so excessive drinking should be avoided while using this medication. During treatment, closely observe blood glucose control status and any unusual symptoms, and consult a doctor immediately if any concerning symptoms arise. Safety and efficacy have not been established for children under 18 years of age, so this medication is not recommended. In case of overdose, serious side effects such as lactic acidosis may occur, so immediate treatment at a medical institution is necessary if suspected. This medication should be kept out of reach of children and stored in the original container to maintain quality.

Side effects

  • Hypoglycemia
  • urinary tract infection
  • genital infection
  • increased urination
  • ketoacidosis
  • lactic acidosis
  • decreased vitamin B12 absorption
  • decreased fluid volume
  • nausea
  • vomiting
Show 191 more
  • diarrhea
  • abdominal pain
  • loss of appetite
  • constipation
  • abnormal liver function tests
  • hepatitis
  • altered taste
  • itching
  • rash
  • hives
  • erythema
  • angioedema
  • dysuria
  • interstitial nephritis
  • thirst
  • increased serum lipids
  • increased serum creatinine
  • decreased glomerular filtration rate
  • chronic gastritis
  • cerebral infarction
  • soft tissue infection
  • pneumonia
  • ankle fracture
  • epicondylitis
  • facial bone fracture
  • musculoskeletal pain
  • myocardial infarction
  • diarrhea
  • nausea
  • gastric ulcer
  • colitis
  • ischemic colitis
  • colonic hemorrhage
  • oral discomfort
  • salivary gland pain
  • headache
  • dizziness
  • positional dizziness
  • weakness
  • chest discomfort
  • chest pain
  • nasopharyngitis
  • upper respiratory infection
  • bronchitis
  • chronic sinusitis
  • gastroenteritis
  • Helicobacter infection
  • periodontitis
  • appendiceal abscess
  • appendicitis
  • chronic tonsillitis
  • conjunctivitis
  • influenza
  • laryngitis
  • meningitis
  • chronic otitis media
  • paronychia
  • peritonsillar abscess
  • pulmonary tuberculosis
  • sepsis
  • subcutaneous abscess
  • tinea corporis
  • dental abscess
  • tubo-ovarian abscess
  • vestibular neuritis
  • upper abdominal pain
  • cavities
  • gastroesophageal reflux disease
  • abdominal distension
  • anal hemorrhage
  • ischemic colitis
  • enteritis
  • bloating
  • gastric polyp
  • gingival swelling
  • bloody stool
  • hemorrhoids
  • pancreatic cyst
  • rectal pain
  • toothache
  • weight loss
  • vulvar pruritus
  • benign prostatic hyperplasia
  • diabetic retinopathy
  • diplopia
  • hypertension
  • insomnia
  • anxiety
  • depression
  • sleep disorders
  • otalgia
  • positional vertigo
  • vertigo
  • anemia
  • lymphadenopathy
  • hypothyroidism
  • thyroid nodule
  • diabetic foot
  • low back pain
  • astigmatism
  • cataract
  • allergic conjunctivitis
  • visual disturbances
  • corneal abrasion
  • glaucoma
  • macular fibrosis
  • eye discomfort
  • conjunctival hyperemia
  • pathological myopia
  • retinal detachment
  • retinal crystals
  • retinal vein occlusion
  • traction retinal detachment
  • eyelid swelling
  • visual impairment
  • floaters
  • vitreous hemorrhage
  • epistaxis
  • asthma
  • exertional dyspnea
  • productive cough
  • allergic rhinitis
  • retained sputum
  • skin laceration
  • contusion
  • rib fracture
  • concussion
  • corneal abrasion
  • falls
  • hand fracture
  • iliotibial band syndrome
  • open eye injury
  • pelvis fracture
  • road traffic accident
  • splenic injury
  • sternum fracture
  • angina
  • palpitations
  • Prinzmetal's angina
  • coronary artery disease
  • tachycardia
  • atherosclerosis
  • deep vein thrombosis
  • diabetic vascular complications
  • peripheral artery occlusive disease
  • benign neoplasm of the ampulla of Vater
  • benign ovarian tumor
  • bladder cancer
  • cholesteatoma
  • gastric cancer
  • leiomyoma
  • pancreatic carcinoma
  • colorectal cancer
  • thyroid cancer
  • uterine leiomyoma
  • acute cholecystitis
  • autoimmune hepatitis
  • cholelithiasis
  • hepatitis
  • otalgia
  • positional vertigo
  • vertigo
  • anemia
  • lymphadenopathy
  • diarrhea
  • dyspepsia
  • abdominal pain
  • nausea
  • gastritis
  • gastrointestinal disorders
  • constipation
  • nasopharyngitis
  • herpes zoster
  • positional dizziness
  • headache
  • chest discomfort
  • chest pain
  • weakness
  • weight loss
  • vulvar pruritus
  • genital pruritus
  • dyslipidemia
  • hyperglycemia
  • low back pain
  • diabetic retinopathy
  • dry eyes
  • cough
  • dyspnea
  • unstable angina
  • hypertension
  • insomnia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air or moisture from entering. It is important to maintain a storage temperature between 1 and 30 degrees Celsius at room temperature. This will help preserve the medication's effectiveness and safety for a longer period.

Appearance and packaging

Appearance

Biconvex oval film-coated tablet with a dark brownish purple color

Package unit

30 tablets/bottle, 60 tablets/bottle, 10 tablets/box (10 tablets/PTP x 1), 60 tablets/box (10 tablets/PTP x 6)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.